Skip to main content

Amneal to Participate at Upcoming Investor Conference

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) announced today that Chirag Patel, Co-Chief Executive Officer and President, and Tasos Konidaris, Chief Financial Officer, will participate in the 2024 Jefferies Healthcare Conference on June 5, 2024.

Chirag will present at 1:30 PM EST. A live webcast of the presentation will be accessible on the Company's website at https://investors.amneal.com. A replay of the webcast will be available following the event.

About Amneal

Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in Bridgewater, NJ, is a global pharmaceuticals company. We make healthy possible through the development, manufacturing, and distribution of a diverse portfolio of over 280 generic and specialty pharmaceuticals, primarily within the United States. In its Generics segment, the Company is expanding across a broad range of complex product categories and therapeutic areas, including injectables and biosimilars. In its Specialty segment, Amneal has a growing portfolio of branded pharmaceuticals focused primarily on central nervous system and endocrine disorders, with a pipeline focused on unmet needs. Through its AvKARE segment, the Company is a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets. For more information, please visit www.amneal.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  217.56
-4.47 (-2.01%)
AAPL  260.08
-2.69 (-1.02%)
AMD  232.80
-5.23 (-2.20%)
BAC  50.93
-0.59 (-1.15%)
GOOG  253.83
+2.49 (0.99%)
META  732.54
-0.73 (-0.10%)
MSFT  523.41
+5.75 (1.11%)
NVDA  180.52
-0.64 (-0.35%)
ORCL  271.82
-3.32 (-1.21%)
TSLA  433.75
-8.85 (-2.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.